Pheton Holdings Ltd - Class A

Research Pheton Holdings Ltd - Class A (ITOC) on Bullrun: market cap USD 57.93M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 57.93M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 523.03K-USD 5.10M-USD 3.24M62.6%-0.32USD 1.49MUSD 143.00KUSD 6.12M
FY2024USD 448.20K-USD 660.59K-USD 775.86K85.0%-0.05USD 6.16MUSD 247.97KUSD 6.18M
FY2023USD 628.59K-USD 241.22K-USD 63.64K74.9%-0.02USD 217.89KUSD 155.82KUSD 306.27K
FY2022USD 679.78KUSD 83.98K-USD 116.15K82.1%0.01USD 72.29KUSD 218.33KUSD 556.32K
FY2021USD 702.78KUSD 192.46KUSD 80.77K84.1%0.03USD 136.75KUSD 297.40KUSD 954.34K

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-09USD 57.93Mn/an/an/a
20252025-12-31USD 5.99Mn/an/an/a
20242024-12-31USD 62.84Mn/an/an/a

About Pheton Holdings Ltd - Class A

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Pheton Holdings Ltd - Class A's market cap?

Pheton Holdings Ltd - Class A's market capitalization is USD 57.93M.

What does Pheton Holdings Ltd - Class A do?

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.